A placebo-controlled trial reported that after 26 weeks of treatment with liraglutide, menstrual frequency increased and ovarian function improved [29]
Mir Ali, MD, board certified bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, who was not involved in the study, said: As far as I know, no definite mechanism to link GLP-1 medications and suicidal ideation [has been described]. He also said, There is disagreement because the incidence [of suicidal ideation] is so rare that it is difficult to accurately assess and try to delineate a possible reason for this. Separating existing psychological stressors from those possibly caused by GLP-1 is also difficult
Oral GLP-1 therapies are gaining attention because they combine the proven benefits of GLP-1 treatment with a dosage form that may be easier for patients to take and easier for healthcare systems to scale
Front Chem 7(3):2141221423
Compliance with federal and provincial research regulations rests with the buyer's institution
Innovation was never a problem
